CVE-2015-2870
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access...
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access-control devices allows remote attackers to inject arbitrary web script or HTML via a SCRIPT element.
Exploit likelihood
What each source reports
NVD Score used
4.3
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access-control devices allows remote attackers to inject arbitrary web script or HTML via a SCRIPT element.
- Record
CVE-2015-2870- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access-control devices allows remote attackers to inject arbitrary web script or HTML via a SCRIPT element.
- Record
CVE-2015-2870- Updated
- 2026-11-02
EUVDEUVD-2015-2958 No score
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access-control devices allows remote attackers to inject arbitrary web script or HTML via a SCRIPT element.
- Record
EUVD-2015-2958- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-3fpr-96rf-fw9f No score
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access...
Cross-site scripting (XSS) vulnerability on Chiyu BF-630, BF-630W, and BF-660C fingerprint access-control devices allows remote attackers to inject arbitrary web script or HTML via a SCRIPT element.
- Record
GHSA-3fpr-96rf-fw9f- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2015-2870 is a medium vulnerability (CVSS 4.3) in Chiyutw Bf-630, published August 1, 2015. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.17%, the 67th percentile. No source names a fixed version.